Pricing of drugs and donations: options for sustainable equity pricing.
AffiliationCampaign for Access to Essential Medicines, Médecins sans Frontières, Geneva, Switzerland. email@example.com
MetadataShow full item record
AbstractEffective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines. Increasingly, drug donations have been established by drug companies, but these are often limited in time, place or use. Measures exist which are more sustainable and will have a greater positive impact on people's health. Principally, these are encouraging generic competition; adopting into national legislation and implementing TRIPS safeguards to gain access to cheaper sources of drugs; differential pricing; creating high volume or high demand through global and regional procurement; and supporting the production of quality generic drugs by developing countries through voluntary licenses if needed, and facilitating technology transfer.
- Access to essential medications for HIV/AIDS in South Africa.
- Authors: Andrews S
- Issue date: 2001 May
- Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
- Authors: Meiners C, Sagaon-Teyssier L, Hasenclever L, Moatti JP
- Issue date: 2011
- Generic drugs battle moves from South Africa to Kenya.
- Authors: Siringi S
- Issue date: 2001 May 19
- A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
- Authors: Weber A, Mills L
- Issue date: 2010 Jun 15
- Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011.
- Authors: Luo J, Oliveira MA, Ramos MB, Maia A, Osorio-de-Castro CG
- Issue date: 2014 Apr 16